Skip to main content
. 2017 Jul 19;38(7):1465–1470. doi: 10.1007/s00246-017-1685-7

Table 5.

Cost of genetic testing by time period

Testing combination Pre-protocol time period Post-protocol time period
n Diagnosis from Testing Cost n Diagnosis from Testing Cost
Karyotype + 22q + CMA 111 18 $464,048.82 0 0 0
Karyotype + 22q 59 4 $92,340.31 0 0 0
Karyotype + CMA 81 24 $284,391.00 12 6 $42,132.00
QPCR + CMA 39 9 $128,124.75 17 3 $55,849.25
Karyotype only 56 33 $50,129.52 21 21 $18,798.57
22q only 34 2 $21,290.18 6 4 $4,019.52
CMA only 61 15 $159,535.13 65 12 $169,996.45
Patients tested 441 105 $1,199,859.71 121 46 $290,795.79
Patients untested 292  0 $0  37  0 $0 
Total 733 105 $1,199,859.71 158 46 $290,795.79
Average Cost per Tested Patients $2720.77 $2403.27
Average Cost per Diagnosis $11,427.24 $6321.65

This table demonstrates the pre-protocol testing patterns and associated cost to the patient in addition to the number of genetic diagnoses made by the test specified. The bolded number reflect total average cost per tested patient and total cost per diagnosis for the two time periods. This demonstrates a post-protocol reduction in average cost per patient who underwent genetic testing by $317.50 and a post-protocol reduction on average cost per diagnosis by $5105.59. CMA Chromosomal Microarray, 22q = 22q11.2 deletion testing